GAO Report Calls for Federal Action to Better Respond to the Impact of Antibiotic Resistance
May 7, 2020
The General Accounting Office (GAO) has released a report titled, “Antibiotic Resistance: Additional Federal Actions Needed to Better Determine Magnitude and Reduce Impact”. The report was conducted at the request of of the Senate Health, Education, Labor, and Pensions and House Energy and Commerce Committees.
GAO was asked to review federal efforts related to (1) surveillance of antibiotic resistance, (2) the development and use of diagnostic testing to identify antibiotic resistance, (3) the development of treatments for resistant infections, and (4) appropriate antibiotic use.
The GAO report makes a number of recommendations, including that the CDC should develop a plan for timely reporting of antibiotic resistance in priority pathogens and that HHS should develop a strategic framework to incentivize development of new treatments for antibiotic-resistant infections. The report also noted that the Combating Antibiotic-Resistant Bacteria Task Force should address in its annual updates to the president ways to remedy barriers to fully implementing the National Action Plan for Combating Antibiotic-Resistant Bacteria.
Recent News
- BD Launches Landmark Cell Analyzer Featuring Breakthrough Spectral and Real-Time Cell Imaging Technologies
- KyphoLift Debuts at ISMRM 2025: Transforming Patient Positioning for Safer, More Accurate Imaging
- Kelvyn Cullimore: An Unfair Penalty on Life-Saving Pills
- Merit Medical Announces Health Canada Approval of the WRAPSODY® Cell-Impermeable Endoprosthesis
- Merit Medical Releases 12-Month Efficacy Results for the Single-Arm Arteriovenous Graft (AVG) Cohort of the WRAPSODY® Arteriovenous Efficacy (WAVE) Trial
- Myriad Genetics Announces RiskScore Study Published in JCO Precision Oncology